Accesso libero

Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy

, , , , ,  e   
27 feb 2025
INFORMAZIONI SU QUESTO ARTICOLO

Cita
Scarica la copertina

Hribernik, Nezka
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Strasek, Katja
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
Studen, Andrej
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
Experimental Particle Physics Department, Jozef Stefan InstituteLjubljana, Slovenia
Zevnik, Katarina
Department of Nuclear Medicine, Institute of Oncology LjubljanaLjubljana, Slovenia
Skalic, Katja
Department of Nuclear Medicine, Institute of Oncology LjubljanaLjubljana, Slovenia
Jeraj, Robert
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
University of Wisconsin Carbone Cancer CentreMadison, USA
Department of Medical Physics, University of Wisconsin-MadisonMadison, USA
Experimental Particle Physics Department, Jozef Stefan InstituteLjubljana, Slovenia
Rebersek, Martina
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina interna, Ematologia, Oncologia, Radiologia